AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2696997 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg t.i.d. after 7-10 days
Number of subjects: 110
Study 2696997 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of 10 mg diazepam after 3-4 hours
Number of subjects: 110
Study 2696997 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 524315 — intervention group
Group type: EXPERIMENTAL
Intervention: High molecular weight heparin fraction (intravenous injection)
Number of subjects: 5
Study 524315 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin fraction (intravenous injection)
Number of subjects: 5
Study 524315 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin fractions (subcutaneous injection)
Number of subjects: 5
Study 524315 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous heparin injection (general)
Number of subjects: 5
Study 524315 — intervention group
Group type: EXPERIMENTAL
Intervention: High molecular weight heparin (general)
Number of subjects: 5
Study 524315 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (general)
Number of subjects: 5
Study 31680339 — intervention group
Group type: EXPERIMENTAL
Intervention: Socket-shield technique (SST)
Number of subjects: 30
Study 31680339 — intervention group
Group type: COMPARATOR
Intervention: Conventional flap-less (control)
Number of subjects: 30
Study 30825258 — intervention group
Group type: EXPERIMENTAL
Intervention: Data-prompted interviews using the Theoretical Domains Framework (TDF)
Number of subjects: 18
Study 30825258 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions that challenge dysfunctional beliefs about adherence and support the development of routines or habits and problem-solving
Number of subjects: 18
Study 28558854 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic yogurt
Number of subjects: 14
Study 28558854 — intervention group
Group type: COMPARATOR
Intervention: Acidified milk
Number of subjects: 14
Study 26093877 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythm control (RhC)
Number of subjects: 1391
Study 26093877 — intervention group
Group type: COMPARATOR
Intervention: Rate control (RaC)
Number of subjects: 1391
Study 24216069 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 PUFAs at a dose of 3 g/day for 8 weeks
Number of subjects: 40
Study 24216069 — intervention group
Group type: COMPARATOR
Intervention: Placebo (corn oil)
Number of subjects: 40
Study 21345849 — intervention group
Group type: EXPERIMENTAL
Intervention: Neopterin levels measured at study entry
Number of subjects: 3946
Study 21345849 — intervention group
Group type: EXPERIMENTAL
Intervention: Neopterin levels added to a multivariable Cox model
Number of subjects: 3946
Study 18556608 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (three 50-minute aerobic sessions each week for 6 months)
Number of subjects: 156
Study 18556608 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 156
Study 17385181 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar coagulating electric vein stripper (EVS)
Number of subjects: 200
Study 17385181 — intervention group
Group type: COMPARATOR
Intervention: Conventional stripping
Number of subjects: 200
Study 16648741 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal stabilization rehabilitation program
Number of subjects: 346
Study 16648741 — intervention group
Group type: COMPARATOR
Intervention: Manual therapy
Number of subjects: 346
Study 16648741 — intervention group
Group type: COMPARATOR
Intervention: Minimal intervention control group
Number of subjects: 346
Study 12859262 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide-5-mononitrate (ISMN), 10 mg
Number of subjects: 10
Study 12859262 — intervention group
Group type: COMPARATOR
Intervention: Timolol maleate (positive control)
Number of subjects: 10
Study 12859262 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 12859262 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide-5-mononitrate (ISMN)
Number of subjects: 10
Study 10609625 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol added to low-dose beclomethasone dipropionate therapy
Number of subjects: 0
Study 10609625 — intervention group
Group type: COMPARATOR
Intervention: Doubling the dose of beclomethasone dipropionate
Number of subjects: 0
Study 8622048 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment regimen for black myeloma patients
Number of subjects: 0
Study 8622048 — intervention group
Group type: COMPARATOR
Intervention: Treatment regimen for white myeloma patients
Number of subjects: 0
Study 1941055 — intervention group
Group type: EXPERIMENTAL
Intervention: 5FU plus low-dose leucovorin
Number of subjects: 457
Study 1941055 — intervention group
Group type: EXPERIMENTAL
Intervention: 5FU plus high-dose leucovorin
Number of subjects: 457
Study 1941055 — intervention group
Group type: COMPARATOR
Intervention: 5FU plus high-dose MTX with leucovorin rescue
Number of subjects: 457
Study 6756832 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 95
Study 6756832 — intervention group
Group type: COMPARATOR
Intervention: Nasogastric suction
Number of subjects: 95
Study 28965930 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 0
Study 28965930 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 27164714 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotigotine (1-3 mg/24 h)
Number of subjects: 81
Study 27164714 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 24186673 — intervention group
Group type: EXPERIMENTAL
Intervention: Metal-on-metal total hip arthroplasties (M2a-Magnum, Biomet)
Number of subjects: 70
Study 24186673 — intervention group
Group type: COMPARATOR
Intervention: Metal-on-polyethylene total hip arthroplasties (Mallory-Head, Biomet)
Number of subjects: 70
Study 24186673 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Metal-on-metal and Metal-on-polyethylene)
Number of subjects: 70
Study 24186673 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum metal ion levels (cobalt, chromium, titanium)
Number of subjects: 70
Study 21733297 — intervention group
Group type: EXPERIMENTAL
Intervention: Richly micronutrient-fortified infant food
Number of subjects: 743
Study 20399406 — intervention group
Group type: EXPERIMENTAL
Intervention: Yogurt intervention (substitution of part of the WIC milk allowance with yogurt)
Number of subjects: 511
Study 20399406 — intervention group
Group type: EXPERIMENTAL
Intervention: Yogurt intervention
Number of subjects: 511
Study 20399406 — intervention group
Group type: EXPERIMENTAL
Intervention: Yogurt intervention (for those in the lowest tertile of yogurt intake at baseline)
Number of subjects: 511
Study 20399406 — intervention group
Group type: COMPARATOR
Intervention: Control group (no yogurt intervention)
Number of subjects: 511
Study 19078833 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial Neural Network (ANN)
Number of subjects: 127
Study 19078833 — intervention group
Group type: COMPARATOR
Intervention: Logistic Regression Model
Number of subjects: 127
Study 15725351 — intervention group
Group type: EXPERIMENTAL
Intervention: CXCL10 and its receptor CXCR3
Number of subjects: 0
Study 15725351 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN-gamma
Number of subjects: 0
Study 12039927 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for prostate cancer with PSA testing
Number of subjects: 20716
Study 12039927 — intervention group
Group type: COMPARATOR
Intervention: No family history
Number of subjects: 20716
Study 12039927 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall screening program
Number of subjects: 20716
Study 10515178 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG)
Number of subjects: 150
Study 10515178 — intervention group
Group type: COMPARATOR
Intervention: Carbamazepine (CBZ)
Number of subjects: 150
Study 7795939 — intervention group
Group type: EXPERIMENTAL
Intervention: External visual imagery group
Number of subjects: 24
Study 7795939 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal visual imagery group
Number of subjects: 24
Study 7795939 — intervention group
Group type: EXPERIMENTAL
Intervention: External visual imagery
Number of subjects: 24
Study 7795939 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal visual imagery
Number of subjects: 24
Study 2026301 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical lidocaine gel
Number of subjects: 30
Study 2026301 — intervention group
Group type: COMPARATOR
Intervention: Oral emepronium bromide
Number of subjects: 30
Study 6779888 — intervention group
Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition
Number of subjects: 24
Study 6779888 — intervention group
Group type: COMPARATOR
Intervention: Gastrostomy feeding
Number of subjects: 24
Study 31566164 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT)
Number of subjects: 230
Study 31566164 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 230
Study 31006684 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized cognitive training (CCT)
Number of subjects: 97
Study 31006684 — intervention group
Group type: COMPARATOR
Intervention: Mailings
Number of subjects: 97
Study 28942715 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl sublingual spray 100 mcg
Number of subjects: 96
Study 28942715 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl sublingual spray 200 mcg
Number of subjects: 96
Study 28942715 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl sublingual spray 400 mcg
Number of subjects: 96
Study 28942715 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl citrate intravenous 50 mcg
Number of subjects: 96
Study 25478944 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg
Number of subjects: 731
Study 25478944 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 731
Study 22789309 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal eccentric exercise of the elbow flexors (60 maximal eccentric elbow flexions)
Number of subjects: 18
Study 22098690 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic Saphenous harvesting with an Open CO2 System
Number of subjects: 230
Study 22098690 — intervention group
Group type: COMPARATOR
Intervention: Conventional vein harvesting
Number of subjects: 230
Study 19308757 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin
Number of subjects: 45
Study 19308757 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Number of subjects: 45
Study 19308757 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration Threshold (VT) measurements
Number of subjects: 45
Study 19308757 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurological tests and questionnaire
Number of subjects: 45
Study 19308757 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up time
Number of subjects: 45
Study 19308757 — intervention group
Group type: EXPERIMENTAL
Intervention: Feet neuropathy
Number of subjects: 45
Study 19308757 — intervention group
Group type: EXPERIMENTAL
Intervention: Other determinants (platinum levels, renal function, glutathione transferase genotypes, diabetes mellitus, alcohol use, co-medication)
Number of subjects: 45
Study 16106400 — intervention group
Group type: EXPERIMENTAL
Intervention: EBV BamH1W assay
Number of subjects: 130
Study 16106400 — intervention group
Group type: EXPERIMENTAL
Intervention: EBV polymerase assay
Number of subjects: 130
Study 16106400 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage III or IV disease
Number of subjects: 130
Study 16106400 — intervention group
Group type: COMPARATOR
Intervention: Community control
Number of subjects: 130
Study 16106400 — intervention group
Group type: EXPERIMENTAL
Intervention: Unaffected family members
Number of subjects: 130
Study 16106400 — intervention group
Group type: EXPERIMENTAL
Intervention: EBV load test
Number of subjects: 130
Study 12684919 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamins (vitamins B, C, and E)
Number of subjects: 1078
Study 12684919 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A (preformed vitamin A and beta carotene)
Number of subjects: 1078
Study 10919528 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 60 mg IM
Number of subjects: 155
Study 10919528 — intervention group
Group type: COMPARATOR
Intervention: Meperidine 1 mg/kg IM
Number of subjects: 155
Study 8974721 — intervention group
Group type: EXPERIMENTAL
Intervention: EGb 761 infusion
Number of subjects: 40
Study 8974721 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 40
Study 1453510 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency two-way jet ventilation (HFTJV)
Number of subjects: 10
Study 1453510 — intervention group
Group type: COMPARATOR
Intervention: High frequency jet ventilation (HFJV)
Number of subjects: 10
Study 6367599 — intervention group
Group type: EXPERIMENTAL
Intervention: Tromaril (enfenamic acid)
Number of subjects: 30
Study 6367599 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 6367599 — intervention group
Group type: EXPERIMENTAL
Intervention: Tromaril
Number of subjects: 30
Study 30504071 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant psychiatric disorders in children with ASD
Number of subjects: 658
Study 30504071 — intervention group
Group type: EXPERIMENTAL
Intervention: ADHD
Number of subjects: 658
Study 28195950 — intervention group
Group type: EXPERIMENTAL
Intervention: Videoconferencing administration of the La Trobe Communication Questionnaire (LCQ)
Number of subjects: 20
Study 28195950 — intervention group
Group type: COMPARATOR
Intervention: In-person administration of the La Trobe Communication Questionnaire (LCQ)
Number of subjects: 20
Study 27276842 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg (2 ml) intravenous 60-90 minutes before surgery
Number of subjects: 80
Study 27276842 — intervention group
Group type: COMPARATOR
Intervention: Normal saline 2 ml 60-90 minutes before surgery
Number of subjects: 80
Study 23937657 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold atmospheric argon plasma treatment for 2 minutes
Number of subjects: 40
Study 23937657 — intervention group
Group type: COMPARATOR
Intervention: Placebo (argon gas) treatment for 2 minutes
Number of subjects: 40
Study 21320138 — intervention group
Group type: EXPERIMENTAL
Intervention: ADX10059 120 mg b.d.
Number of subjects: 103
Study 21320138 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study 19153758 — intervention group
Group type: EXPERIMENTAL
Intervention: 12% O(2) exposure
Number of subjects: 10
Study 19153758 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% O(2) exposure
Number of subjects: 10
Study 19153758 — intervention group
Group type: EXPERIMENTAL
Intervention: 21% O(2) exposure
Number of subjects: 10
Study 16984929 — intervention group
Group type: EXPERIMENTAL
Intervention: valsartan
Number of subjects: 14703
Study 16984929 — intervention group
Group type: EXPERIMENTAL
Intervention: captopril
Number of subjects: 14703
Study 16984929 — intervention group
Group type: EXPERIMENTAL
Intervention: combination of valsartan and captopril
Number of subjects: 14703
Study 16984929 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 14703
Study 15006283 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E
Number of subjects: 8171
Study 15006283 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C
Number of subjects: 8171
Study 15006283 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene
Number of subjects: 8171
Study 15006283 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid/vitamin B(6)/vitamin B(12)
Number of subjects: 8171
Study 15006283 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8171
Study 15006283 — intervention group
Group type: COMPARATOR
Intervention: Placebo for folic acid/vitamin B(6)/vitamin B(12)
Number of subjects: 8171
Study 11317143 — intervention group
Group type: EXPERIMENTAL
Intervention: Running (4-5 km)
Number of subjects: 17
Study 11317143 — intervention group
Group type: COMPARATOR
Intervention: Control (sedentary)
Number of subjects: 17
Study 9734406 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based visual restitution training (VRT)
Number of subjects: 38
Study 9734406 — intervention group
Group type: COMPARATOR
Intervention: Placebo training
Number of subjects: 38
Study 7662044 — intervention group
Group type: EXPERIMENTAL
Intervention: Acamprosate 2.0 g/day (high dose group)
Number of subjects: 538
Study 7662044 — intervention group
Group type: EXPERIMENTAL
Intervention: Acamprosate 1.3 g/day (low dose group)
Number of subjects: 538
Study 7662044 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 538
Study 7662044 — intervention group
Group type: EXPERIMENTAL
Intervention: Acamprosate groups (both doses)
Number of subjects: 538
Study 7662044 — intervention group
Group type: EXPERIMENTAL
Intervention: Acamprosate
Number of subjects: 538
Study 2751161 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfuric acid aerosols (20 microns)
Number of subjects: 0
Study 2751161 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfuric acid aerosols (10 microns)
Number of subjects: 0
Study 2751161 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfuric acid aerosols (1 micron)
Number of subjects: 0
Study 2751161 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfuric acid exposures (in asthmatics)
Number of subjects: 0
Study 2751161 — intervention group
Group type: COMPARATOR
Intervention: Control conditions (purified water aerosols)
Number of subjects: 0
Study 339785 — intervention group
Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 12
Study 339785 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol
Number of subjects: 12
Study 339785 — intervention group
Group type: COMPARATOR
Intervention: Simulated acupuncture
Number of subjects: 12
Study 339785 — intervention group
Group type: COMPARATOR
Intervention: Nebulized saline
Number of subjects: 12
Study 339785 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 12
Study 30738826 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinuation of antihypertensive medication
Number of subjects: 0
Study 30738826 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 0
Study 28713032 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive Disclosure (AD) therapy
Number of subjects: 186
Study 28713032 — intervention group
Group type: COMPARATOR
Intervention: Present-Centered Therapy (PCT)
Number of subjects: 186
Study 25312783 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-combination therapy with Pre + TAC + CTX
Number of subjects: 18
Study 25312783 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-combination therapy with Pre + TAC + MMF
Number of subjects: 18
Study 25312783 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-combination therapy with Pre + TAC + LEF
Number of subjects: 18
Study 25312783 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-combination therapy with Pre + TAC + CTX/MMF/LEF
Number of subjects: 18
Study 23168287 — intervention group
Group type: EXPERIMENTAL
Intervention: VWF multimer ratio
Number of subjects: 66
Study 23168287 — intervention group
Group type: EXPERIMENTAL
Intervention: PFA‐CADP
Number of subjects: 66
Study 23168287 — intervention group
Group type: EXPERIMENTAL
Intervention: VWF high‐molecular‐weight multimers
Number of subjects: 66
Study 23168287 — intervention group
Group type: EXPERIMENTAL
Intervention: VWF latex agglutination immunoturbidic activity/VWF antigen ratio
Number of subjects: 66
Study 23168287 — intervention group
Group type: EXPERIMENTAL
Intervention: BNP
Number of subjects: 66
Study 23168287 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleeding
Number of subjects: 66
Study 23168287 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptoms
Number of subjects: 66
Study 21256669 — intervention group
Group type: EXPERIMENTAL
Intervention: Sterile sodium chloride (NaCl) 0.9% irrigation
Number of subjects: 23
Study 21256669 — intervention group
Group type: COMPARATOR
Intervention: Tap water (H2O) irrigation
Number of subjects: 23
Study 21256669 — intervention group
Group type: EXPERIMENTAL
Intervention: Sterile sodium chloride (NaCl) 0.9% solution
Number of subjects: 23
Study 19300114 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive measures (structured physician‐patient interaction, printed information about hypertension, reminder stickers, 24 h timer, home BP measurement device)
Number of subjects: 202
Study 19300114 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive measures
Number of subjects: 202
Study 19300114 — intervention group
Group type: COMPARATOR
Intervention: Standard care (no supportive measures)
Number of subjects: 202
Study 16999640 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic counseling intervention
Number of subjects: 48
Study 16999640 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 48
Study 14607553 — intervention group
Group type: EXPERIMENTAL
Intervention: hMG
Number of subjects: 2030
Study 14607553 — intervention group
Group type: COMPARATOR
Intervention: recombinant FSH
Number of subjects: 2030
Study 10487373 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-year moderate intensity aerobic and strength training exercise program (monitored group exercise sessions plus home exercise)
Number of subjects: 168
Study 10487373 — intervention group
Group type: COMPARATOR
Intervention: Control program (stretching classes)
Number of subjects: 168
Study 9551128 — intervention group
Group type: EXPERIMENTAL
Intervention: Balinese dance exercise 3 x 50 min per week for 8 weeks
Number of subjects: 60
Study 9551128 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 60
Study 2006658 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment
Number of subjects: 800
Study 2006658 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 800
Study 7272177 — intervention group
Group type: EXPERIMENTAL
Intervention: Caroxazone 200 mg three times daily
Number of subjects: 6
Study 7272177 — intervention group
Group type: EXPERIMENTAL
Intervention: Caroxazone treatment
Number of subjects: 6
Study 7272177 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-treatment (after discontinuation of caroxazone)
Number of subjects: 6
Study 7272177 — intervention group
Group type: EXPERIMENTAL
Intervention: Caroxazone
Number of subjects: 6
Study 2418305 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 0